Anti-enolase antibodies partially protective against systemic candidiasis in mice

Clinical Microbiology and Infection

Volumn 2, Issue 1, 1996, Pages 36-43

  Van Deventet, Hanneke J ^a   Goessens, Wil H ^a   Van Vliet, Arjen J ^a   Verbrugh, Henry A ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Anti enolase antibodies; Immunoprotection; Systemic candidiasis

Indexed keywords

EID: 1842510397     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1996.tb00198.x     Document Type: Article

References (28)

1. Cantora MT, Balish E. Acquired immunity to systemic candidiasis in immunodeficient mice. J Infect Dis 1991; 164: 936-43.
2. Vecchiarrelli A, Mazzolla R, Farinelli S, Cassone A, Bistoni F. Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection. J General Microbiol 1988; 134: 2583-92.
3. Giger DK, Domer JE, Moser SA, McQuitty JT Jr. Experimental murine candidiasis: pathological and immune responses in T-lymphocyte-depleted mice. Infect Immun 1978; 21: 729-37.
4. Greenfield RA. Host defense system interactions with Candida. J Med Vet Mycol 1992; 30: 89-104.
5. Hurtel B, Lagrange PH, Michel J-C. Systemic candidiasis in mice. Main role of polymorphonuclear leucocytes in resistance to infection. Ann Immunol 1980; 131C: 105-18.
6. Maiti PK, Kumar A, Kumar R, Mohapatra. Role of antibodies and effect of BCG vaccination in experimental candidiasis in mice. Mycopathologia 1985; 91: 79-85.
7. Hasenclever HF, Mitchell WO. Acquired immunity to candidiasis in mice. J Bacteriol 1962; 86: 401-6.
8. Cantorna M, Balish E. Reply [letter]. J Infect Dis 1992; 166: 194-5.
9. Mourad S, Friedman L. Passive immunization of mice against Candida albicans. Sabouraudia 1986; 6: 103-5.
10. Pearsall NN, Lagunoff D. Immunological responses to Candida albicans I. Mouse-thigh lesion as model for experimental candidiasis. Infect Immun 1974; 9: 999-1002.
11. Matthews RC, Burnie JP, Howat D, Rowland T, Walton F. Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology 1991; 74: 20-4.
12. Garner RE, Domer JE. Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis. Infect Immun 1994; 62: 738-41.
13. Vecchiarelli A, Cenci E, Puliti M, et al. Protective immunity induced by low-virulence Candida albicans: cytokine production in the development of the anti-infectious state. Cellular Immunol 1989; 124: 334-44.
14. Jones GR, Warnock W. Observations on the use of double diffusion test in the diagnosis of vaginal candidiasis. J Clin Pathol 1977; 30: 262-5.
15. van Deventer AJM, van Vliet HJA, Voogd L, Hop WCJ, Goessens WHF. Increased specificity of antibody detection in surgical patients with invasive candidiasis with cytoplasmic antigens depleted of mannan residues. J Clin Microbiol 1993; 31: 994-7.
16. Ellsworth JH, Reiss E, Bradley RL, Chmel H, Armstrong D. Comparative serological and cutaneous reactivity of candidal cytoplasmic and mannan separated by affinity for concanavalin A. J Clin Microbiol 1977; 5: 91-9.
17. van Deventer AJM, van Vliet HJA, Hop WCJ, Goessens WHF. Diagnostic value of anti-Candida enolase antibodies. J Clin Microbiol 1994; 32: 17-23.
18. Porsius JC, van Vliet HJA, van Zeijl JH, Goessens WHF, Michel MF. Detection of antibody response in immunocompetent patients with systemic candidiasis or Candida albicans colonisation. Eur J Clin Microbiol Infect Dis 1990; 9: 352-5.
19. Mirza IH, Wilkin TJ, Cantarini, Moore K. A comparison of spleen and lymph node cells as fusion partners for the raising of monoclonal antibodies after different routes of immunisation. J Immunol Methods 1987; 105: 235-43.
20. Ollert MW, Calderone RA. A monoclonal antibody that defines a surface antigen on Candida albicans hyphae cross-react with yeast cell protoplasts. Infect Immun 1990; 58: 625-31.
21. van Etten EWM, van den Heuvel-de Groot C, Bakker-Woudenberg IAJM. Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (Ambisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leukopenic mice. J Antimicrob Chemother 1993; 32: 723-39.
22. van Etten EWM, van de Rhee NE, van Kampen KM, Bakker-Woudenberg IAJM. Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans. Antimicrob Agents Chemother 1991; 35: 2275-81.
23. Kagaya K, Shinoda T, Fukazawa Y. Murine defense mechanism against Candida albicans infection. Microbiol Immunol 1981; 25: 647-54.
24. Miyake T, Takeya K, Nomoto K, Muraoka S. Cellular elements in the resistance to Candida infection in mice. Microbiol Immunol 1977; 21: 703-25.
25. Rogers TJ, Balish E. Immunity to Candida albicans. Microbiol Rev 1980; 44: 660-82.
26. Pereira HA, Hosking CS. The role of complement in opsonization and intracellular killing of Candida albicans. Clin Exp Immunol 1984; 57: 307-314.
27. Sohnle PG, Frank MM, Kirkpatrick CH. Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs. J Immunol 1976; 117: 523-30.
28. Kuruganti U, Henderson LA, Garner RE, Asofsky R, Baker PJ, Domer JE. Non specific and Candida-specific immune responses in mice suppressed by chronic administration of anti-μ. J Leukocyte Biol 1988; 44: 422-33.